Robert H Weiss, MD


  • 4731 Citations
  • 38 h-Index
1991 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Robert H Weiss is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


  • Research Output

    Introduction: Why do we need a special volume on kidney cancer?

    Weiss, R. H., Jan 1 2020, (Accepted/In press) In : Seminars in Nephrology.

    Research output: Contribution to journalEditorial

    Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy

    Sinha, S., Dwivedi, N., Tao, S., Jamadar, A., Kakade, V. R., Neil, M. O., Weiss, R. H., Enders, J., Calvet, J. P., Thomas, S. M. & Rao, R., Feb 6 2020, In : Oncogene. 39, 6, p. 1231-1245 15 p.

    Research output: Contribution to journalArticle

  • The cell-cycle regulatory protein p21cip1/waf1 is required for cytolethal distending toxin (Cdt)-induced apoptosis

    Shenker, B. J., Walker, L. M., Zekavat, A., Weiss, R. H. & Boesze-Battaglia, K., Jan 2020, In : Pathogens. 9, 1, 38.

    Research output: Contribution to journalArticle

    Open Access
  • Open Access
  • 1 Scopus citations

    Targeting the insulin-like growth factor-1 receptor in MTAP-deficient renal cell carcinoma

    Xu, J., Chang, W. H., Fong, L. W. R., Weiss, R. H., Yu, S. L. & Chen, C-H., Dec 1 2019, In : Signal Transduction and Targeted Therapy. 4, 1, 2.

    Research output: Contribution to journalArticle